Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 11—November 2010

CME ACTIVITY

Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008

Clarisse A. TsangComments to Author , Shoana M. Anderson, Sara B. Imholte, Laura M. Erhart, Sanny Chen, Benjamin J. Park, Cara Christ, Kenneth K. Komatsu, Tom Chiller, and Rebecca H. Sunenshine
Author affiliations: Arizona Department of Health Services, Phoenix, Arizona, USA (C.A. Tsang, S.M. Anderson, S.B. Imholte, L.M. Erhart, S. Chen, C. Christ, K.K. Komatsu, R.H. Sunenshine); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Chen, B.J. Park, T. Chiller, R.H. Sunenshine)

Main Article

Table 2

Clinical and behavioral characteristics of enhanced surveillance coccidioidomycosis patients, Arizona, USA, January 2007–February 2008*

Characteristic No. (%)
Coexisting condition
Heart disease 62 (13)
Lung disease 90 (18)
Asthma requiring inhaler 47 (10)
COPD or emphysema 27 (6)
Other 29 (6)
Malignancy 70 (14)
Transplant 11 (2)
HIV 9 (2)
Diabetes mellitus 72 (15)
None
164 (33)
Immunosuppression†
97 (20)
Smoker
Active 76 (15)
Past 203 (41)
Never 202 (41)
Unknown
12 (2)
Site of infection, n = 282
Primary pulmonary‡ 240 (85)
Disseminated§ 42 (15)

*N = 493. COPD, chronic obstructive pulmonary disease.
†Immunosuppression is defined as having HIV/AIDS, a solid-organ transplant, or a bone marrow transplant or taking immunosuppressive medications. Immunosuppressive medications refer to medications that suppress the immune system and include chemotherapy medications such as steroids, prednisone, dexamethasone, infliximab, or interferon, as self-reported by patients.
‡Primary pulmonary infection is defined as the lungs being the only site of infection, as self-reported by patients.
§Disseminated infection is defined as infection spread to other parts of the body, including the central nervous system, bone, and entire body, as self-reported by patients.

Main Article

TOP